141 related articles for article (PubMed ID: 12506025)
1. The PML gene is not involved in the regulation of MHC class I expression in human cell lines.
Bruno S; Ghiotto F; Fais F; Fagioli M; Luzi L; Pelicci PG; Grossi CE; Ciccone E
Blood; 2003 May; 101(9):3514-9. PubMed ID: 12506025
[TBL] [Abstract][Full Text] [Related]
2. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.
Zheng P; Guo Y; Niu Q; Levy DE; Dyck JA; Lu S; Sheiman LA; Liu Y
Nature; 1998 Nov; 396(6709):373-6. PubMed ID: 9845074
[TBL] [Abstract][Full Text] [Related]
4. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies.
Dent AL; Yewdell J; Puvion-Dutilleul F; Koken MH; de The H; Staudt LM
Blood; 1996 Aug; 88(4):1423-6. PubMed ID: 8695863
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of PML and PML/RAR alpha on STAT3 activity.
Kawasaki A; Matsumura I; Kataoka Y; Takigawa E; Nakajima K; Kanakura Y
Blood; 2003 May; 101(9):3668-73. PubMed ID: 12506013
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
Topisirovic I; Capili AD; Borden KL
Mol Cell Biol; 2002 Sep; 22(17):6183-98. PubMed ID: 12167712
[TBL] [Abstract][Full Text] [Related]
7. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
Flenghi L; Fagioli M; Tomassoni L; Pileri S; Gambacorta M; Pacini R; Grignani F; Casini T; Ferrucci PF; Martelli MF
Blood; 1995 Apr; 85(7):1871-80. PubMed ID: 7535592
[TBL] [Abstract][Full Text] [Related]
10. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
11. A cytoplasmic PML mutant inhibits p53 function.
Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
[TBL] [Abstract][Full Text] [Related]
12. [Research advances on function of promyelocytic leukemia (PML) protein].
He PC; Zhang M; Wang F
Ai Zheng; 2003 Dec; 22(12):1359-62. PubMed ID: 14693070
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
[TBL] [Abstract][Full Text] [Related]
15. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
16. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
18. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
[TBL] [Abstract][Full Text] [Related]
19. The biologic function of PML and its role in acute promyelocytic leukemia.
Mu ZM; Le XF; Glassman AB; Chang KS
Leuk Lymphoma; 1996 Oct; 23(3-4):277-85. PubMed ID: 9031108
[TBL] [Abstract][Full Text] [Related]
20. [Progress in researches on the function of PML gene].
Zhou L; Chen G; Shen Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):132-5. PubMed ID: 10751540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
